In vitro fertilization in Sweden: child morbidity including cancer risk

Bengt Källén1, Orvar Finnström, Karl-Gösta Nygren

  • 1Tornblad Institute, University of Lund, Lund, Sweden. embryol@embryol.lu.se

Fertility and Sterility
|September 20, 2005
PubMed

Insights

Children conceived via in vitro fertilization (IVF) experience higher long-term morbidity, particularly related to preterm births and certain diagnoses. Cancer risk was not generally increased, though histiocytosis cases were noted.

Area of Science:

  • Reproductive Medicine
  • Pediatric Health
  • Epidemiology

Background:

  • In vitro fertilization (IVF) is a common assisted reproductive technology.
  • Understanding the long-term health outcomes for children born after IVF is crucial.

Purpose of the Study:

  • To investigate long-term morbidity in children conceived through IVF compared to naturally conceived infants.
  • To identify specific health conditions and risk factors associated with IVF conception.

Main Methods:

  • A Swedish national register study comparing over 16,000 IVF children with a control group of all infants born.
  • Data analyzed included hospital care duration, specific diagnoses, and childhood cancer incidence.

Main Results:

  • IVF children showed increased hospital care use up to age six, partly due to maternal factors.
  • Diagnoses related to brain damage and other conditions were overrepresented, often linked to preterm births.
  • While overall cancer risk was not elevated, an unexpected number of Langerhan's histiocytosis cases were observed.

Conclusions:

  • Long-term morbidity is higher in IVF children, influenced by preterm and multiple births.
  • Parental factors may also play a role in healthcare utilization.
  • No general cancer risk increase was found, but a notable increase in histiocytosis warrants further investigation.
Abstract

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...